Reviews

TrimRx is a telehealth company that provides GLP-1 medication for weight loss. It makes tried-and-tested medications like semaglutide available to people more easily in compounded form at affordable prices. The treatment is highly personalized and provided under the supervision of a board-certified physician. In addition to weight-loss goals, the treatment also considers your health goals, pre-existing conditions, and nutritional deficiencies. The medication is compounded, meaning it’s custom-made by licensed pharmacies and contains the same active ingredient (semaglutide). The company is based in San Diego, California, but provides services nationwide. Their goal is to make these medications accessible to the masses who may not be able to afford or access brand-name options like Ozempic or Wegovy.

SnagRx is a telehealth weight-loss brand operated by Modern Metabolic Medicine, Inc., based in Wilmington, Delaware. Medical care is provided by OpenLoop Health, a network of US-licensed physicians who review each patient’s intake and determine eligibility for GLP-1 treatment; OpenLoop’s clinicians retain the final decision on whether to prescribe. SnagRx also has its own medical director, a practicing physician who reviews the doctor and pharmacy network for safety. The brand reports 125,000+ customers and is LegitScript certified, meaning its pharmacy, doctor network, and software providers have been independently verified for compliance. SnagRx offers compounded semaglutide and compounded tirzepatide only; it does not dispense FDA-approved brand-name GLP-1 medications. Prescriptions are filled by one of four named, US-based 503A compounding pharmacies (RedRock Pharmacy, Health Warehouse, Precision Compounding Pharmacy, and Triad Rx), which prepare medication for individual patients under state pharmacy board licensing and federal compounding law. SnagRx is available in every US state except Louisiana; in Nebraska, service is limited to patients 19 and older.

Embody is a telehealth weight loss service designed to help you access doctor-led GLP-1 treatment from home. Instead of visiting a clinic in person, you complete an online evaluation, have your information reviewed by licensed professionals, and, if approved, receive a personalized care plan and prescription support. The brand focuses on convenience, predictable pricing, fast shipping, and ongoing support, making it appealing if you want a more guided alternative to losing weight on your own. Embody offers both injection and oral options, with pricing starting at $149/month on the offer page and including all doses under its flat-price messaging. The company also highlights patient-reported results, saying Embody patients lose an average of 15–20% of their body weight during the program.

Noom is a digital health company focused on weight loss and healthy lifestyles. It was founded in 2008 as a mobile app that initially offered calorie tracking and fitness. Since then, the app has transformed into a comprehensive weight loss program backed by behavioral science. The Noom app takes a personalized approach to weight loss, with monitoring tools and health coaches providing support. It also tracks biometrics like blood pressure and blood sugar if you log such information. Noom turns to psychology to cause lasting behavioral changes, using cognitive behavior therapy (CBT) principles to enforce healthier eating habits. The company started with the Noom Weight program, which uses the app to help users achieve their weight goals. Noom Med is an extension of the original program, using prescription injection medication alongside the app to help individuals overcome chronic conditions causing weight gain. Recently, Noom expanded its offerings to include compounded semaglutide and a unique “Microdose” program, making GLP-1 treatments significantly more accessible and affordable.

With WellMedr, you get a fully online weight-loss platform built around clinician-guided GLP-1 care, home delivery, and ongoing support. You start online, complete a guided intake, connect with a licensed U.S. clinician, and receive a treatment plan tailored to your goals, body, and progress. The brand also highlights unlimited messaging, a real-time care platform, discreet shipping, and ongoing refill support. WellMedr positions itself as a newer, modern telehealth option rather than a legacy clinic, emphasizing convenience, personalization, and ongoing digital support. It includes licensed U.S. providers, regulated pharmacy partners, privacy policies, and telehealth consent.

AltRx is an online weight loss treatment service that gives you access to prescription-based GLP-1 and GLP-1/GIP options through a fully digital process. Instead of booking an in-person appointment, calling around for availability, or trying to work through insurance delays, you can complete your medical intake online and have your eligibility reviewed by a licensed clinician. The brand focuses on convenience, transparent pricing, and at-home treatment support. You can choose from compounded GLP-1 options, GLP-1/GIP options, and branded treatments such as Ozempic and Mounjaro, depending on your eligibility and what a medical provider decides is appropriate for you. AltRx also includes virtual consultations, prescription processing, shipping, and customer support in its care model, which makes it appealing if you want a more streamlined weight loss treatment experience without traditional clinic visits.

Found is a brand that offers tailored weight loss programs based on GLP-1 medications, including Ozempic, Wegovy, and Zepbound. The brand established in 2019, has helped over 300k members achieve their weight loss goals through its personalized weight care subscriptions. Found has recently expanded eligibility to adults aged 65–75, and now accepts Medicare. Headed by senior medical advisor, Dr Rekha Kumar, Found focuses on making critical weight care accessible, through telehealth channels, providing support and convenience. The process includes a questionnaire that is followed by a clinician review. A program is then put together for your body, and your GLP-1 is then delivered, discreetly to your door. Found doesn’t leave it there, giving you access to ongoing care and support, through regular provider check-ins, prescription adjustments, an online community, and Aimee, an AI health concierge. These services are accessible through Found’s subscription plans, which cater to users with and without insurance.

Ro provides seamless healthcare services from diagnosis to medication delivery, all from the comfort of home. As a leading telehealth company, Ro offers personalized treatment plans in areas such as sexual health, fertility, weight loss, and skin and hair health. Ro complements primary care physicians, focusing on improving adult well-being with expedited medication delivery, typically within 4-6 weeks. Founded in 2017 in New York City by Zachariah Reitano, Saman Rahmanian, and Rob Schutz, Ro merges technology with healthcare. Ro is accredited by the Better Business Bureau (BBB) with an A- rating. All Ro healthcare professionals are U.S. licensed, with background checks and license verifications conducted.

Noom is a digital health company focused on weight loss and healthy lifestyles. It was founded in 2008 as a mobile app that initially offered calorie tracking and fitness. Since then, the app has transformed into a comprehensive weight loss program backed by behavioral science. The Noom app takes a personalized approach to weight loss, with monitoring tools and health coaches providing support. It also tracks biometrics like blood pressure and blood sugar if you log such information. Noom turns to psychology to cause lasting behavioral changes, using cognitive behavior therapy (CBT) principles to enforce healthier eating habits. The company started with the Noom Weight program, which uses the app to help users achieve their weight goals. Noom Med is an extension of the original program, using prescription injection medication alongside the app to help individuals overcome chronic conditions causing weight gain. Recently, Noom expanded its offerings to include compounded semaglutide and a unique “Microdose” program, making GLP-1 treatments significantly more accessible and affordable.